Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-24 @ 2:12 PM
NCT ID:
NCT07138495
Eligibility Criteria:
Inclusion Criteria
* ≥ 6 months post-stroke
* Patients presenting a first-ever ischemic or intracerebral hemorrhagic stroke
* Mild to Moderate unilateral upper limb motor impairment: Medical Research Council proximal and distal upper limb MRC ≥2; Action Research Arm Test: ARAT score \< 50 (0 = no function, 57 = no functional limitation).
* Age \> 18 years old
* Able to sit on a chair or a wheelchair and interact with RGS during an entire session
* Minimal experience with smartphone technology based on the clinician's opinion
* Willing to participate in the RGS therapy
* Sign the Informed Consent Form
Exclusion Criteria
* Diagnosis with Epilepsy
* Severe cognitive capabilities preventing the execution of the experiment or according to clinicians' criteria.
* Severe associated impairment such as proximal but not distal spasticity, communication disabilities (sensory, Wernicke aphasia or apraxia), major pain (VAS \> 75-100 mm), orthopedic devices that would interfere with the correct execution of the experiment (Modified Ashworth Scale \> 3)
* Unable to use the RGS app independently according to the clinician's observations and lacking support from a caregiver to use the RGS app
* No experience with smartphone technology or based on the clinician's opinion.
* Refusal to sign the Informed Consent
* Participating or planning to participate in another trial while being part of the present study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07138495
Study Brief:
Protocol Section:
NCT07138495